VHL and nonpapillary renal cell carcinoma: Our previous study demonstrated that VHL regulates chronic inflammation in ccRCC progressionvia the LCN-2–ROS pathway [22]; however, the critical role of vhl mutations in LCN-2 regulation of ccRCC formation via the ferroptotic-inflammatory pathway is unclear.